A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Start Date
11/29/2022
Completion Date
11/1/2026
Summary
The researchers are doing this study to look at how butyrate levels change in participants' stool after they are on a- plant-based diet for at least 12 weeks. All participants will have monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). We will compare how the plant-based diet, omega-3 fatty acid and curcumin supplements, and placebo (an inactive substance that looks like the study supplements) affect butyrate levels in participants' stool.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Whole Foods Plant-based Diet
Algae Omega 3 + Curcumin
Placebo supplements
Conditions
Locations
Emory University (Data Collection Only)
Atlanta, Georgia 30322
United States
Memorial Sloan Kettering Basking Ridge (All Protocol Activities)
Basking Ridge, New Jersey 07920
United States
Memorial Sloan Kettering Monmouth (All Protocol Activities)
Middletown, New Jersey 07748
United States
Memorial Sloan Kettering Bergen (All Protocol Activities)
Montvale, New Jersey 07645
United States
Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities)
Commack, New York 11725
United States
Memorial Sloan Kettering Westchester (All Protocol Activities)
Harrison, New York 10604
United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
United States
Memorial Sloan Kettering Nassau (All Protocol Activities)
Uniondale, New York 11553
United States